Hubei Biocause Pharmaceutical Free Cash Flow Generation Index
Hubei Biocause Pharmaceutical free cash flow generation index. Hubei Biocause Pharmaceutical (000627) has a Free Cash Flow Generation Index of 0.96x as of September 2023. Free cash flow of CN¥265.55 Million represents 1% of operating cash flow (CN¥276.06 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Hubei Biocause Pharmaceutical (2001–2023)
Free cash flow generation index of Hubei Biocause Pharmaceutical from 2001 to 2023. Historical FCF Generation Index trend for Hubei Biocause Pharmaceutical across 16 annual periods. See financial flexibility index of Hubei Biocause Pharmaceutical to measure the company's free cash flow as a share of total liabilities.
Hubei Biocause Pharmaceutical Free Cash Flow Generation Index by Year (2001–2023)
Hubei Biocause Pharmaceutical free cash flow generation index by year from 2001 to 2023. Year-by-year Free Cash Flow Generation Index for Hubei Biocause Pharmaceutical. For the full cash flow conversion analysis, see Hubei Biocause Pharmaceutical (000627) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.99x | CN¥9.47 Billion | CN¥9.53 Billion | CN¥67.53 Million | ▲ +1.1% |
| 2022 | 0.98x | CN¥7.39 Billion | CN¥7.52 Billion | CN¥135.06 Million | ▲ +5.5% |
| 2021 | 0.93x | CN¥3.89 Billion | CN¥4.17 Billion | CN¥287.13 Million | ▼ -5.5% |
| 2020 | 0.99x | CN¥21.11 Billion | CN¥21.42 Billion | CN¥319.51 Million | ▲ +1.1% |
| 2019 | 0.97x | CN¥27.88 Billion | CN¥28.60 Billion | CN¥717.10 Million | ▼ -0.7% |
| 2018 | 0.98x | CN¥14.71 Billion | CN¥14.98 Billion | CN¥274.67 Million | ▲ +222.0% |
| 2017 | -0.80x | CN¥-347.37 Million | CN¥431.58 Million | CN¥778.95 Million | ▼ -138.3% |
| 2013 | 2.10x | CN¥274.33 Million | CN¥130.53 Million | CN¥143.80 Million | ▼ -11.3% |
| 2012 | 2.37x | CN¥222.29 Million | CN¥93.79 Million | CN¥128.50 Million | ▼ -26.6% |
| 2011 | 3.23x | CN¥216.32 Million | CN¥66.95 Million | CN¥149.37 Million | ▲ +128.4% |
| 2010 | 1.41x | CN¥317.67 Million | CN¥224.58 Million | CN¥93.09 Million | ▼ -8.5% |
| 2007 | 1.55x | CN¥183.32 Million | CN¥118.56 Million | CN¥64.76 Million | ▼ -23.3% |
| 2006 | 2.02x | CN¥258.31 Million | CN¥128.19 Million | CN¥130.12 Million | ▲ +34.0% |
| 2005 | 1.50x | CN¥73.17 Million | CN¥48.66 Million | CN¥24.51 Million | ▲ +3.3% |
| 2004 | 1.46x | CN¥81.59 Million | CN¥56.07 Million | CN¥25.52 Million | ▼ -21.1% |
| 2001 | 1.84x | CN¥68.77 Million | CN¥37.30 Million | CN¥31.47 Million | — |